Showing results (161-170 of 332) with videos related to

Sort By:
Pageof 34
The Journal of Sexual Medicine|June 7, 2017
Off-Label Use of Phosphodiesterase Type 5 Inhibitor Erectile Dysfunction Medication to Enhance Sex Among Gay and Bisexual Men in Australia: Results From the FLUX StudyMohamed A Hammoud, Fengyi Jin, Toby Lea, et al.
Drug and Alcohol Review|August 14, 2012
Trends in drug use among gay and bisexual men in Sydney, Melbourne and Queensland, AustraliaToby Lea, Garrett Prestage, Limin Mao, et al.
Pain Medicine (Malden, Mass.)|October 9, 2019
Development of a Brief Patient-Administered Screening Tool for Prescription Opioid Dependence for Primary Care SettingsSuzanne Nielsen, Louisa Picco, Gabrielle Campbell, et al.
LGBT Health|July 25, 2022
Differences in Alcohol and Other Drug Use and Dependence Between Transgender and Cisgender Participants from the 2018 Global Drug SurveyDean J Connolly, Emma Davies, Michael Lynskey, et al.
Substance Abuse Treatment, Prevention, and Policy|October 8, 2022
Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorderLlewellyn Mills, Adrian Dunlop, Mark Montebello, et al.
The British Journal of Psychiatry : the Journal of Mental Science|September 14, 2013
Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addictionSarah Byford, Barbara Barrett, Nicola Metrebian, et al.
Drug and Alcohol Review|November 21, 2013
Diversion of prescribed opioids by people living with chronic pain: results from an Australian community sampleJessica Belcher, Suzanne Nielsen, Gabrielle Campbell, et al.
Drug and Alcohol Review|July 31, 2015
Treating codeine dependence with buprenorphine: Dose requirements and induction outcomes from a retrospective case series in New South Wales, AustraliaSuzanne Nielsen, Raimondo Bruno, Bridin Murnion, et al.
Drug and Alcohol Review|February 4, 2025
Treatment satisfaction and patient reported outcomes among people with opioid use disorder participating in an open-label, non-randomised trial of long-acting injectable buprenorphine treatment in Australian custodial settingsBethany White, Sophia Little, Paul S Haber, et al.
Drug and Alcohol Review|July 17, 2015
Injecting buprenorphine-naloxone film: Findings from an explorative qualitative studyNancy White, Ian Flaherty, Peter Higgs, et al.
Pageof 34